<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38423">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01784822</url>
  </required_header>
  <id_info>
    <org_study_id>12-013</org_study_id>
    <nct_id>NCT01784822</nct_id>
  </id_info>
  <brief_title>Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair</brief_title>
  <official_title>Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Hybrid Graft study is a post-market observational study to collect data on the
      performance of the Hybrid Graft when used to reinforce or bridge the abdominal wall for the
      repair of ventral hernias.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Rate of hernia recurrence</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Ventral Hernias</condition>
  <arm_group>
    <arm_group_label>Hybrid Graft</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hybrid Graft</intervention_name>
    <description>Hybrid Graft for ventral hernia repair</description>
    <arm_group_label>Hybrid Graft</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from University of Tennessee, Duke University and Cleveland Clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary or recurrent ventral hernia

          -  Need for abdominal wall repair with reinforcement or bridging material to obtain the
             desired surgical result

        Exclusion Criteria:

          -  Age &lt; 21 (i.e., infants, children)

          -  Device intended to be used in an infected wound

          -  Known sensitivity to porcine material

          -  Pregnant or planning pregnancy in the future

          -  Life expectancy of less than 12 months from the date of the index procedure

          -  Hernia too large to be covered with a single device with at least 4-5 cm of tissue
             overlap on all sides
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brenda Johnson</last_name>
    <phone>765-463-7537</phone>
    <email>bmjohnson@medinst.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Thomason</last_name>
      <phone>919-470-7038</phone>
      <email>Emily.thomason@duke.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Libertini</last_name>
      <phone>216-445-4148</phone>
      <email>LIBERTL@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Tennessee</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Rawn</last_name>
      <phone>865-305-9227</phone>
      <email>srawn@utmck.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 14, 2014</lastchanged_date>
  <firstreceived_date>February 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ventral hernia</keyword>
  <keyword>Graft repair</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
